Hypertension Flashcards
normal BP followup time
1 year
elevated BP followup time and tx
3-6 months, non pharm
stage 1 tx and followup
ASC >10% or comorbid = nonpharm + 1 agent - 1 month
ASCVD <10% = nonpharm - 3-6 months
stage 2 tx and followup
nonpharm and 2+ agents - 1 month
HTN pts at goal followup time?
3-6 months
tx initiation BP for ASCVD >10% or CVD
130/80
tx initiation for diabetes
130/80
tx initiation for secondary stroke
140/90
SPRINT trial pts and outcome
no diabtetes/stroke
tighter BP goal decreased CV events 25%
ACCORD trial pts and outcome
diabetes and CVD
no death benefit with tighter goal
decrease stroke risk 41%
stable ischemic heart disease agents
ACE/ARB or beta blocker
if angina: dihydropyridine CCB
heart failure reduced ejection fraction agent
avoid non-DHP CCBS
heart failure preserved ejection fraction agent
ACE/ARB, diuretic, beta blocker
CKD agent
ACE/ARB if albuminuria >300
renal transplant agent
DHP CCB
secondary stroke prevention agent
ACE/ARB and/or thiazide only if BP >140/90
diabetes agents
any first line
ACE/ARB if proteinuria
atrial fib agents
ARB
black patients without CKD or HF agents
thiazide or CCB
pregnancy agents
methyldopa
nifedipine
labetalol
thiazide diuretics drugs
HCTZ, chlorthalidone, indapamide, metalozone
thiazides are more effective for pts with a CrCl > what
> 30 mL/min
hydrochlorothiazide max dose and dosing
25 mg daily
chlorthalidone max dose and dosing
100 mg daily